New program aims to tackle obesity in kids with down syndrome

NCT ID NCT07296861

Recruiting now Disease control Sponsor: UNC Lineberger Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 6-month family-based program called HomeGrown, designed to help parents of young children (ages 2-6) with Down syndrome create healthier home environments. Families get online tools, resources, and monthly coaching calls to improve nutrition and physical activity. The trial will first check if families find the program easy to use and stick with it, then later measure its impact on health behaviors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (healthy eating and physical activity coaching via online tools and phone calls)
What this could lead to: If it works, this could provide a practical, family-friendly program to help young children with Down syndrome develop healthier habits and reduce obesity risk.
What could go wrong: This is a small early-stage trial (38 families) testing feasibility, not yet proven to work. The program relies on family engagement, which may vary, and results may not apply to all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILD OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Down syndrome Pediatric Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILD OBESITY DOWN SYNDROME

Contacts and locations

Locations

UNC Center for Health Promotion and Disease Prevention
RECRUITING

Chapel Hill, North Carolina, 27599-7426, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.